» Articles » PMID: 29467448

Identification of the Fungal Ligand Triggering Cytotoxic PRR-mediated NK Cell Killing of Cryptococcus and Candida

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Feb 23
PMID 29467448
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) cells use the activating receptor NKp30 as a microbial pattern-recognition receptor to recognize, activate cytolytic pathways, and directly kill the fungi Cryptococcus neoformans and Candida albicans. However, the fungal pathogen-associated molecular pattern (PAMP) that triggers NKp30-mediated killing remains to be identified. Here we show that β-1,3-glucan, a component of the fungal cell wall, binds to NKp30. We further demonstrate that β-1,3-glucan stimulates granule convergence and polarization, as shown by live cell imaging. Through Src Family Kinase signaling, β-1,3-glucan increases expression and clustering of NKp30 at the microbial and NK cell synapse to induce perforin release for fungal cytotoxicity. Rather than blocking the interaction between fungi and NK cells, soluble β-1,3-glucan enhances fungal killing and restores defective cryptococcal killing by NK cells from HIV-positive individuals, implicating β-1,3-glucan to be both an activating ligand and a soluble PAMP that shapes NK cell host immunity.

Citing Articles

Persistent NK cell deficiency associated with pulmonary cryptococcosis.

Martinot M, Li S, Farnarier C, Dubrou C, Piperoglou C, Mody C Ann Clin Microbiol Antimicrob. 2025; 24(1):6.

PMID: 39827096 PMC: 11742195. DOI: 10.1186/s12941-024-00771-7.


Recognition of Self and Viral Ligands by NK Cell Receptors.

Mariuzza R, Singh P, Karade S, Shahid S, Sharma V Immunol Rev. 2025; 329(1):e13435.

PMID: 39748148 PMC: 11695704. DOI: 10.1111/imr.13435.


State of the Field: Cytotoxic Immune Cell Responses in and Infection.

Okafor E, Nielsen K J Fungi (Basel). 2024; 10(10).

PMID: 39452664 PMC: 11508571. DOI: 10.3390/jof10100712.


Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies.

Lee S, Kim J, Jang I, Jo S, Lee S, Oh S Int J Mol Sci. 2024; 25(19).

PMID: 39408655 PMC: 11476788. DOI: 10.3390/ijms251910326.


The activating receptor NKG2D is an anti-fungal pattern recognition receptor.

Charpak-Amikam Y, Kournos M, Kotzur R, Isaacson B, Bagad Brenner T, Gomez-Cesar E Nat Commun. 2024; 15(1):8664.

PMID: 39375344 PMC: 11458907. DOI: 10.1038/s41467-024-52913-2.


References
1.
Song M, di Luzio N . Yeast glucan and immunotherapy of infectious diseases. Front Biol. 1979; 48:533-47. View

2.
Hidore M, Murphy J . Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans. Infect Immun. 1989; 57(7):1990-7. PMC: 313832. DOI: 10.1128/iai.57.7.1990-1997.1989. View

3.
Kullberg B, Arendrup M . Invasive Candidiasis. N Engl J Med. 2015; 373(15):1445-56. DOI: 10.1056/NEJMra1315399. View

4.
Babineau T, Hackford A, Kenler A, Bistrian B, Forse R, Fairchild P . A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg. 1994; 129(11):1204-10. DOI: 10.1001/archsurg.1994.01420350102014. View

5.
Williams D, Cook J, Hoffmann E, di Luzio N . Protective effect of glucan in experimentally induced candidiasis. J Reticuloendothel Soc. 1978; 23(6):479-490. View